Skip to main content
Fig. 3 | Molecular Cancer

Fig. 3

From: Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma

Fig. 3

MIAC directly binds to AQP2. Immunoprecipitation (IP) and IB with anti-MIAC (A) or anti-AQP2 (B). C Molecular docking analysis of the MIAC and AQP2. MST (D) and SPR (E) analysis of the direct intearction between MIAC and AQP2. F, G Biotin-MIAC pulldown with HA-tagged AQP2 or site-directed mutants based on the molecular docking analysis in 293 T

Back to article page

Molecular Cancer

ISSN: 1476-4598